Revelation Biosciences Inc (REVB) — Long-term Investment Intensity

Latest as of December 2019: 6.8%

Revelation Biosciences Inc (REVB) has a Long-term Investment Intensity of 6.8% as of December 2019. Long-term investments of $194.09 Million represent 6.8% of total assets of $2.85 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Revelation Biosciences Inc (REVB) shareholders funds for net asset value and shareholders' equity analysis.

LT Investment Intensity

6.8%
LT Investments / Total Assets

Long-term Investments

$194.09 Million
USD

Total Assets

$2.85 Billion
USD

Country

USA
NASDAQ

Revelation Biosciences Inc Long-term Investment Intensity (2016–2019)

This chart shows how Revelation Biosciences Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 6.8%, reflecting long-term investments of $194.09 Million against total assets of $2.85 Billion USD. Also explore REVB total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Revelation Biosciences Inc (2016–2019)

The table below presents the year-by-year Long-term Investment Intensity for Revelation Biosciences Inc from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Revelation Biosciences Inc market cap and net worth.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2019 856115.7% $194.09 Million $22.67K ▲ +856107.9 pp
2018 7.8% $192.26 Million $2.46 Billion ▼ -0.2 pp
2017 8.0% $168.38 Million $2.10 Billion ▲ +0.4 pp
2016 7.7% $144.91 Million $1.89 Billion
pp = percentage points